- --------------------------------------------------------------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE
ACT OF 1934
Date of Report (Date of earliest event reported)
April 15, 1998
GENUS, INC.
-----------
(Exact name of registrant as specified in its charter)
CALIFORNIA
----------
(State or other jurisdiction of incorporation or organization)
0-17139 94-2790804
------- ----------
Commission File Number (I.R.S. Employer Identification Number)
1139 KARLSTAD DRIVE
SUNNYVALE, CA 94089
-------------------
(Address of principal executive offices)
(408) 747-7120
--------------
(Registrant's telephone number, including area code)
- --------------------------------------------------------------------------------
ITEM 5. OTHER EVENTS
On April 15, 1998, Genus, Inc., a California corporation (the
"Registrant"), signed a definitive agreement to sell to Varian Associates, Inc.,
a Delaware corporation , ("Varian"), substantially all of the assets of the
Registrant's ion implantations systems business (the "Business"), and to grant
to Varian a royalty free, nonexclusive, irrevocable, worldwide, perpetual
license covering the Registrant's intellectual property related to the
Business, excluding any such intellectual property primarily used in the conduct
of the Registrant's chemical vapor and thin film deposition systems business.
The agreement anticipates a purchase price of $25 million in cash, subject
to adjustment under certain circumstances. The transaction requires approval of
the shareholders of the Registrant and satisfaction of certain other conditions
prior to closing.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS
(c) EXHIBITS (in accordance with Item 601 of Regulation S-K)
2.1 Asset Purchase Agreement, dated April 15, 1998, by and
between Varian Associates, Inc. and Registrant and exhibits
thereto.
Certain exhibits and schedules to the Asset Purchase
Agreement are listed on page (iv) thereto and the Registrant
agrees to furnish them supplementally to the Securities and
Exchange Commission upon request; provided, however, that
the Registrant reserves the right to seek confidential
treatment for those exhibits and schedules which it deems
confidential.
99.1 Press Release dated April 16, 1998
-2-
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunder duly authorized.
GENUS, INC.
Date: April 24, 1998 /s/ Mary F. Bobel
--------------------------------------
Mary F. Bobel
Executive Vice President and
Chief Financial Officer
-3-
INDEX TO EXHIBITS
EXHIBIT
NUMBER EXHIBIT NAME
- --------------------------------------------------------------------------------
2.1 Asset Purchase Agreement, dated April 15, 1998, by and between
Varian Associates, Inc. and Registrant and exhibits thereto.
99.1 Press Release dated April 16, 1998.
-4-